The frequent expression of ODF4 within TCC tumor tissues and its correlation with the expression data from urine correctly negates that the expression pattern of ODF4 at mRNA level was in response to the BPH, but not to the TCC status (unpublished data). Here, ODF4 is linked to benign prostatic hyperplasia.